Protagenic Therapeutics, Inc.\new Quarterly Depreciation in USD from Q1 2016 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Protagenic Therapeutics, Inc.\new quarterly/annual Depreciation history and growth rate from Q1 2016 to Q2 2024.
  • Protagenic Therapeutics, Inc.\new Depreciation for the quarter ending June 30, 2024 was $12.6K, a 13714% increase year-over-year.
  • Protagenic Therapeutics, Inc.\new annual Depreciation for 2023 was $28.2K, a 93960% increase from 2022.
  • Protagenic Therapeutics, Inc.\new annual Depreciation for 2022 was $30.000.
  • Protagenic Therapeutics, Inc.\new annual Depreciation for 2020 was $286.000, a 15.6% decline from 2019.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $12.6K +$12.5K +13714% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $12.6K +$12.5K +13869% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q2 2023 $91.00 Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $90.00 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2020 $84.00 -$1 -1.18% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q1 2019 $85.00 -$4 -4.49% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-18
Q1 2018 $89.00 -$828 -90.3% Jan 1, 2018 Mar 31, 2018 10-Q/A 2019-05-16
Q1 2017 $917 +$835 +1018% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q1 2016 $82.00 Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.